Ontrak, Inc. (OTRKP)
USD 0.23
(0.0%)
USD 0.23
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 29.47 Million USD | -54.03% |
| 2022 | 50.23 Million USD | -30.18% |
| 2021 | 71.94 Million USD | 32.85% |
| 2020 | 54.15 Million USD | 56.07% |
| 2019 | 34.7 Million USD | 96.24% |
| 2018 | 17.68 Million USD | 46.66% |
| 2017 | 12.05 Million USD | 34.28% |
| 2016 | 8.97 Million USD | -2.09% |
| 2015 | 9.17 Million USD | 42.96% |
| 2014 | 6.41 Million USD | 2.07% |
| 2013 | 6.28 Million USD | -27.17% |
| 2012 | 8.63 Million USD | -24.92% |
| 2011 | 11.49 Million USD | -15.89% |
| 2010 | 13.66 Million USD | -29.13% |
| 2009 | 19.28 Million USD | -58.84% |
| 2008 | 46.84 Million USD | -12.93% |
| 2007 | 53.8 Million USD | 25.08% |
| 2006 | 43.01 Million USD | 65.21% |
| 2005 | 26.03 Million USD | 114.52% |
| 2004 | 12.13 Million USD | 235.28% |
| 2003 | 3.62 Million USD | 793.85% |
| 2002 | 404.99 Thousand USD | 35.07% |
| 2001 | 299.83 Thousand USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 5.39 Million USD | -19.66% |
| 2024 Q2 | 5.33 Million USD | 4.9% |
| 2023 Q3 | 6.73 Million USD | -0.66% |
| 2023 Q2 | 6.78 Million USD | -19.73% |
| 2023 FY | 23.09 Million USD | -54.03% |
| 2023 Q4 | 6.7 Million USD | -0.45% |
| 2023 Q1 | 8.45 Million USD | -11.37% |
| 2022 Q3 | 11.53 Million USD | -15.22% |
| 2022 Q4 | 9.53 Million USD | -17.34% |
| 2022 FY | 50.23 Million USD | -30.18% |
| 2022 Q1 | 15.55 Million USD | -6.35% |
| 2022 Q2 | 13.6 Million USD | -12.53% |
| 2021 Q4 | 16.61 Million USD | -8.76% |
| 2021 FY | 71.94 Million USD | 32.85% |
| 2021 Q2 | 19.61 Million USD | 4.06% |
| 2021 Q1 | 18.85 Million USD | 6.82% |
| 2021 Q3 | 18.2 Million USD | -7.19% |
| 2020 Q4 | 17.64 Million USD | 26.41% |
| 2020 Q1 | 11.1 Million USD | -6.32% |
| 2020 Q3 | 13.96 Million USD | 22.08% |
| 2020 Q2 | 11.43 Million USD | 2.95% |
| 2020 FY | 54.15 Million USD | 56.07% |
| 2019 Q2 | 8.22 Million USD | 30.54% |
| 2019 Q4 | 11.85 Million USD | 42.49% |
| 2019 FY | 34.7 Million USD | 96.24% |
| 2019 Q1 | 6.29 Million USD | 51.56% |
| 2019 Q3 | 8.32 Million USD | 1.2% |
| 2018 Q3 | 5.17 Million USD | 15.68% |
| 2018 FY | 17.68 Million USD | 46.66% |
| 2018 Q1 | 3.87 Million USD | 2.35% |
| 2018 Q2 | 4.47 Million USD | 15.65% |
| 2018 Q4 | 4.15 Million USD | -19.75% |
| 2017 Q1 | 2.66 Million USD | 13.1% |
| 2017 FY | 12.05 Million USD | 34.28% |
| 2017 Q4 | 3.78 Million USD | 44.24% |
| 2017 Q3 | 2.62 Million USD | -12.16% |
| 2017 Q2 | 2.98 Million USD | 11.88% |
| 2016 Q3 | 2.23 Million USD | 3.0% |
| 2016 Q4 | 2.35 Million USD | 5.64% |
| 2016 Q2 | 2.16 Million USD | -2.3% |
| 2016 FY | 8.97 Million USD | -2.09% |
| 2016 Q1 | 2.21 Million USD | 13.62% |
| 2015 Q1 | 2.76 Million USD | 63.69% |
| 2015 Q4 | 1.95 Million USD | -2.25% |
| 2015 FY | 9.17 Million USD | 42.96% |
| 2015 Q3 | 1.99 Million USD | -18.52% |
| 2015 Q2 | 2.45 Million USD | -11.42% |
| 2014 Q3 | 1.62 Million USD | -6.39% |
| 2014 Q2 | 1.73 Million USD | 13.31% |
| 2014 Q4 | 1.69 Million USD | 4.0% |
| 2014 FY | 6.41 Million USD | 2.07% |
| 2014 Q1 | 1.53 Million USD | 2.0% |
| 2013 Q2 | 1.64 Million USD | -1.61% |
| 2013 Q1 | 1.67 Million USD | -5.52% |
| 2013 FY | 6.28 Million USD | -27.17% |
| 2013 Q4 | 1.5 Million USD | 3.16% |
| 2013 Q3 | 1.45 Million USD | -11.64% |
| 2012 Q3 | 2.01 Million USD | -7.99% |
| 2012 FY | 8.63 Million USD | -24.92% |
| 2012 Q1 | 2.65 Million USD | -8.55% |
| 2012 Q2 | 2.19 Million USD | -17.39% |
| 2012 Q4 | 1.77 Million USD | -11.96% |
| 2011 Q2 | 2.99 Million USD | -4.34% |
| 2011 Q4 | 2.89 Million USD | 17.8% |
| 2011 FY | 11.49 Million USD | -15.89% |
| 2011 Q1 | 3.13 Million USD | -15.43% |
| 2011 Q3 | 2.46 Million USD | -17.94% |
| 2010 Q2 | 3.38 Million USD | -11.47% |
| 2010 Q3 | 2.78 Million USD | -17.77% |
| 2010 Q4 | 3.7 Million USD | 33.11% |
| 2010 Q1 | 3.82 Million USD | -10.94% |
| 2010 FY | 13.66 Million USD | -29.13% |
| 2009 Q4 | 4.29 Million USD | 3.49% |
| 2009 FY | 19.28 Million USD | -58.84% |
| 2009 Q3 | 4.15 Million USD | -14.02% |
| 2009 Q2 | 4.82 Million USD | -19.63% |
| 2009 Q1 | 6 Million USD | -35.44% |
| 2008 Q1 | 14.19 Million USD | 12.97% |
| 2008 Q2 | 12.04 Million USD | -15.16% |
| 2008 Q4 | 9.3 Million USD | -17.69% |
| 2008 Q3 | 11.3 Million USD | -6.11% |
| 2008 FY | 46.84 Million USD | -12.93% |
| 2007 Q3 | 15.5 Million USD | 14.13% |
| 2007 Q2 | 13.58 Million USD | 11.94% |
| 2007 Q1 | 12.14 Million USD | 7.36% |
| 2007 FY | 53.8 Million USD | 25.08% |
| 2007 Q4 | 12.56 Million USD | -19.0% |
| 2006 Q2 | 10.56 Million USD | 7.19% |
| 2006 Q1 | 9.85 Million USD | 7.84% |
| 2006 Q4 | 11.3 Million USD | 0.22% |
| 2006 FY | 43.01 Million USD | 65.21% |
| 2006 Q3 | 11.28 Million USD | 6.79% |
| 2005 Q1 | 4.68 Million USD | 37.21% |
| 2005 FY | 26.03 Million USD | 114.52% |
| 2005 Q4 | 9.14 Million USD | 28.42% |
| 2005 Q3 | 7.11 Million USD | 39.66% |
| 2005 Q2 | 5.09 Million USD | 8.82% |
| 2004 FY | 12.13 Million USD | 235.28% |
| 2004 Q4 | 3.41 Million USD | 11.5% |
| 2004 Q3 | 3.06 Million USD | 20.18% |
| 2004 Q1 | 3.11 Million USD | 23.15% |
| 2004 Q2 | 2.54 Million USD | -18.29% |
| 2003 Q1 | 44.33 Thousand USD | -70.64% |
| 2003 FY | 3.62 Million USD | 793.85% |
| 2003 Q2 | 201 Thousand USD | 353.37% |
| 2003 Q4 | 2.53 Million USD | 185.02% |
| 2003 Q3 | 888 Thousand USD | 341.79% |
| 2002 Q4 | 150.98 Thousand USD | 1.7% |
| 2002 FY | 404.99 Thousand USD | 35.07% |
| 2002 Q3 | 148.46 Thousand USD | 70.82% |
| 2002 Q2 | 86.91 Thousand USD | 366.7% |
| 2002 Q1 | 18.62 Thousand USD | 0.0% |
| 2001 FY | 299.83 Thousand USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| CareCloud, Inc. | 93.35 Million USD | 68.428% |
| Augmedix, Inc. | 40.3 Million USD | 26.87% |
| BrightSpring Health Services, Inc. Common Stock | 1.28 Billion USD | 97.709% |
| CareCloud, Inc. | 93.35 Million USD | 68.428% |
| HealthEquity, Inc. | 401.74 Million USD | 92.663% |
| iCoreConnect Inc. | 15.12 Million USD | -94.888% |
| Inovalon Holdings, Inc. | 427.99 Million USD | 93.113% |
| Nutex Health, Inc. | 66.54 Million USD | 55.709% |
| Omnicell, Inc. | 534.79 Million USD | 94.489% |
| OneMedNet Corporation | 8.24 Million USD | -257.431% |
| Progyny, Inc. | 176.61 Million USD | 83.311% |
| Renalytix Plc | 29.04 Million USD | -1.494% |
| Schrödinger, Inc. | 318.14 Million USD | 90.735% |
| Simulations Plus, Inc. | 37.02 Million USD | 20.381% |
| SOPHiA GENETICS SA | 117.73 Million USD | 74.966% |
| Streamline Health Solutions, Inc. | 31.19 Million USD | 5.499% |
| GE HealthCare Technologies Inc. | 5.48 Billion USD | 99.463% |
| Sharecare, Inc. | 225.97 Million USD | 86.956% |
| Aclarion, Inc. | 4.87 Million USD | -504.534% |
| CareMax, Inc. | 670.05 Million USD | 95.601% |
| Bullfrog AI Holdings, Inc. Common Stock | 5.42 Million USD | -443.085% |
| Forian Inc. | 20.59 Million USD | -43.087% |
| Bullfrog AI Holdings, Inc. Warrants | 5.42 Million USD | -443.085% |
| HeartBeam, Inc. | 15.31 Million USD | -92.471% |
| GeneDx Holdings Corp. | 224.28 Million USD | 86.858% |
| SCWorx Corp. | 2.71 Million USD | -983.743% |
| Minerva Surgical, Inc. | 58.14 Million USD | 49.304% |
| Definitive Healthcare Corp. | 546.47 Million USD | 94.606% |
| 10x Genomics, Inc. | 674.94 Million USD | 95.633% |
| Zhongchao Inc. | 13.92 Million USD | -111.708% |
| Accolade, Inc. | 306.51 Million USD | 90.384% |
| MSP Recovery, Inc. | 565.43 Million USD | 94.787% |
| R1 RCM Inc. | 336.6 Million USD | 91.243% |
| Spok Holdings, Inc. | 90.97 Million USD | 67.602% |
| Privia Health Group, Inc. | 134.31 Million USD | 78.056% |
| EUDA Health Holdings Limited | 4.8 Million USD | -513.662% |
| TruBridge, Inc. | 206.17 Million USD | 85.704% |
| BrightSpring Health Services, Inc. Tangible Equity Unit | 1.28 Billion USD | 97.709% |
| Sharecare, Inc. | 225.97 Million USD | 86.956% |
| Health Catalyst, Inc. | 258.73 Million USD | 88.608% |
| GoodRx Holdings, Inc. | 710.34 Million USD | 95.851% |
| Premier, Inc. | 683.65 Million USD | 95.689% |
| HealthStream, Inc. | 168.02 Million USD | 82.458% |
| Certara, Inc. | 254.08 Million USD | 88.4% |
| GeneDx Holdings Corp. | 224.28 Million USD | 86.858% |
| Ontrak, Inc. | 29.47 Million USD | 0.0% |
| SHL Telemedicine Ltd. | 34.26 Million USD | 13.984% |
| CareCloud, Inc. | 93.35 Million USD | 68.428% |
| EUDA Health Holdings Limited | 4.8 Million USD | -513.662% |
| HeartBeam, Inc. | 15.31 Million USD | -92.471% |
| Mangoceuticals, Inc. | 9.65 Million USD | -205.428% |
| CareMax, Inc. | 670.05 Million USD | 95.601% |
| Healthcare Triangle, Inc. | 18.12 Million USD | -62.621% |
| National Research Corporation | 52.52 Million USD | 43.879% |
| Aclarion, Inc. | 4.87 Million USD | -504.534% |
| OptimizeRx Corporation | 69.3 Million USD | 57.469% |